Cargando…
Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study
OBJECTIVE: To study the oncological safety of diagnostic hysteroscopy for women with apparent early-stage type II endometrial cancer. PATIENTS AND METHODS: A total of 429 women with presumed early-stage type II endometrial cancer were included. The 5-year disease-free survival (DFS) and overall surv...
Autores principales: | Zhou, Hui, Lai, Kai-Fa, Xiang, Qian, Xu, Yu, Zhang, Qian-Wen, Hu, Cui, Mao, Xi-Guang, Chen, Cheng, Huang, Wu, Mi, Gong-Sheng, Shen, Juan, Tian, Yong, Ke, Feng-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259840/ https://www.ncbi.nlm.nih.gov/pubmed/35814398 http://dx.doi.org/10.3389/fonc.2022.918693 |
Ejemplares similares
-
The Oncology Safety of Diagnostic Hysteroscopy in Early-Stage Endometrial Cancer: A Systematic Review and Meta-Analysis
por: Du, Yi, et al.
Publicado: (2021) -
Oncological safety of hysteroscopy in the diagnosis of stage I endometrial cancer: protocol for a systematic review and meta-analysis
por: Xu, Yu, et al.
Publicado: (2020) -
Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
por: Tian, Yong, et al.
Publicado: (2022) -
The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021) -
Diagnostic value of the apparent diffusion coefficient in differentiating malignant from benign endometrial lesions
por: Scepanovic, Bojana, et al.
Publicado: (2023)